# Diclofenac as a KMO Inhibitor

> **NCT06029296** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 12 (estimated)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Diclofenac
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06029296
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-31
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06029296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06029296, "Diclofenac as a KMO Inhibitor". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06029296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*